Oral fenofibrate for hyperbilirubinemia in term neonates: A single-blind randomized controlled trial

Abstract Background: Hyperbilirubinemia is common in the neonatal period; however, delayed diagnosis or inadequate treatment can cause irreparable damage to the neonates. We aimed to evaluate the efficacy of oral fenofibrate for hyperbilirubinemia in term neonates. Methods: This single-blind ran...

Full description

Bibliographic Details
Main Authors: Seyed Hossein Saadat, Rakhshaneh Goodarzi, Babak Gharaei
Format: Article
Language:English
Published: Cambridge University Press 2023-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866123000353/type/journal_article